We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

132 hedge funds and large institutions have $572M invested in Wave Life Sciences in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

279% more call options, than puts

Call options by funds: $549K | Put options by funds: $145K

113% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 16

69% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 32

22% more capital invested

Capital invested by funds: $469M → $572M (+$103M)

15% more funds holding

Funds holding: 115 → 132 (+17)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

2.05% less ownership

Funds ownership: 77.91% → 75.86% (-2%)

Holders
132
Holders Change
+17
Holders Change %
+14.78%
% of All Funds
1.9%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
34
Increased
54
Reduced
32
Closed
16
Calls
$549K
Puts
$145K
Net Calls
+$404K
Net Calls Change
-$951K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$5.61M
2
AG
Artal Group
Luxembourg
+$5.23M
3
BlackRock
BlackRock
New York
+$5.05M
4
IC
Ikarian Capital
Texas
+$2.95M
5
Morgan Stanley
Morgan Stanley
New York
+$2.83M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$9.5M
2
MS
Maven Securities
Jersey
-$7.34M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.2M
4
Primecap Management
Primecap Management
California
-$4.42M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
NM
26
Newtyn Management
New York
$3.08M -$50.1K -10,000 -2%
SCM
27
Silverarc Capital Management
Massachusetts
$3.06M +$2.48M +495,471 New
Connor, Clark & Lunn Investment Management (CC&L)
28
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.85M +$2.32M +462,582 New
JP Morgan Chase
29
JP Morgan Chase
New York
$2.81M -$34.6K -6,906 -1%
Charles Schwab
30
Charles Schwab
California
$2.68M +$1.32M +263,884 +156%
Two Sigma Investments
31
Two Sigma Investments
New York
$2.57M +$1.95M +390,182 +1,470%
Wellington Management Group
32
Wellington Management Group
Massachusetts
$2.46M +$626K +125,006 +46%
Goldman Sachs
33
Goldman Sachs
New York
$2.1M -$253K -50,454 -13%
AllianceBernstein
34
AllianceBernstein
Tennessee
$2.08M +$1.63M +324,689 +2,728%
Marshall Wace
35
Marshall Wace
United Kingdom
$1.93M -$935K -186,804 -37%
AAA
36
Affinity Asset Advisors
New York
$1.77M +$1.44M +286,585 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.76M +$1.43M +285,092 New
TD Asset Management
38
TD Asset Management
Ontario, Canada
$1.55M +$231K +46,200 +22%
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$1.49M +$148K +29,483 +14%
N
40
Nuveen
North Carolina
$1.38M +$78K +15,579 +7%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$1.22M +$87.4K +17,460 +10%
BFM
42
Boothbay Fund Management
New York
$1.06M +$861K +171,926 New
Renaissance Technologies
43
Renaissance Technologies
New York
$1.02M +$751K +149,920 +1,020%
Swiss National Bank
44
Swiss National Bank
Switzerland
$966K +$20.5K +4,100 +3%
PCM
45
Prelude Capital Management
New York
$890K +$723K +144,300 New
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$832K +$7.36K +1,470 +1%
CS
47
Credit Suisse
Switzerland
$794K +$84.1K +16,789 +15%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$751K +$35.8K +7,147 +6%
Arrowstreet Capital
49
Arrowstreet Capital
Massachusetts
$702K +$570K +113,840 New
TI
50
Trexquant Investment
Connecticut
$695K +$403K +80,513 +251%
1
2
3 4 5

WVE Hedge Fund Activity: Q1 2024 in Review

132 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2024, worth a combined $572M — up 22% from $469M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new WVE positions and 16 closed out — a net gain of 18 holders — while 54 added to existing stakes and 32 trimmed.

The largest buyer was Millennium Management, adding an estimated $5.61M. The largest seller was Citadel Advisors, cutting an estimated $9.5M.

  • 132 institutional investors held Wave Life Sciences (WVE) as of Q1 2024, up from 115 in Q4 2023.
  • Funds reported $572M of Wave Life Sciences stock for Q1 2024, up 22% quarter-over-quarter.
  • 34 funds opened new Wave Life Sciences positions in Q1 2024 and 16 closed out, a net change of +18 holders.
  • The largest Wave Life Sciences buyer in Q1 2024 was Millennium Management, an estimated $5.61M added.
  • The largest Wave Life Sciences seller in Q1 2024 was Citadel Advisors, an estimated $9.5M sold.

Based on aggregated 13F filings for Q1 2024.